OBCI Ocean Bio-Chem
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
April 19, 2021
OCEAN BIO-CHEM, INC.
(Exact name of registrant as specified in charter)
|(State or Other Jurisdiction|
|(Commission File Number)||(I.R.S. Employer|
|4041 S.W. 47 Avenue, Fort Lauderdale, Florida||33314|
|(Address of principal executive offices)||(Zip Code)|
(Registrant’s telephone number, including area code)
|☐||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|☐||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|☐||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|☐||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Emerging growth company ☐
If an emerging growth company indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
|Title of each class||Trading Symbol(s)||Name of each exchange on which registered|
|Common Stock, $0.01 par value||OBCI||The NASADQ Stock Market|
Item 2.02. Results of Operations and Financial Condition
On April 19, 2021 Ocean Bio-Chem, Inc. (the “Company”) issued a press release announcing sales results for the first quarter ended March 31, 2021. A copy of the press release is furnished as Exhibit 99.1 to this Current Report.
The information furnished pursuant to Item 2.02 of this Current Report, including the exhibit furnished herewith, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into future filings by the Company under the Securities Act of 1933, as amended, or under the Securities Exchange Act of 1934, as amended, unless the Company expressly sets forth in such future filing that such information is to be considered “filed” or incorporated by reference therein.
Item 9.01 Financial Statements and Exhibits
The Company is furnishing the following exhibit to this Current Report:
|99.1||Press Release, dated April 19, 2021|
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|OCEAN BIO-CHEM, INC.|
|Date: April 20, 2021||By:||/s/ Jeffrey S. Barocas|
|Jeffrey S. Barocas|
|Chief Financial Officer|